Foley Hoag advised H.I.G. BioHealth Partners and Accelmed Partners on the deal.H.I.G. BioHealth Partners and Accelmed Partners acted as new investors and co-leads in the $52…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
